Factors associated with oral glucocorticoid use in patients with rheumatoid arthritis: a drug use study from a prospective national biologics registry-Reference-Cited by-同舟云学术

Factors associated with oral glucocorticoid use in patients with rheumatoid arthritis: a drug use study from a prospective national biologics registry

Published:2017-11-15 Issue:1 Volume:19 Page:
ISSN:1478-6362
Container-title:Arthritis Research & Therapy
language:en
Short-container-title:Arthritis Res Ther

Author:

Black Rachel J.,Lester Susan,Buchbinder Rachelle,Barrett Claire,Lassere Marissa,March Lyn,Whittle Samuel,Hill Catherine L.

Funder

RJB is supported by an Australian Postgraduate Award and an Arthritis South Australia/Australian Rheumatology Association (South Australia) Postgraduate Grant.

RB is funded by an NHMRC Senior Principal Research Fellowship.

ARAD receives educational grant and project funding from Pfizer Australasia, Abbvie Australia Pty. Ltd, Bristol Myers Squibb, Celgene and Sanofi.

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1186/s13075-017-1461-3.pdf

Reference22 articles.

1. Sokka T, Kautiainen H, Toloza S, Makinen H, Verstappen SM, Lund Hetland M, Naranjo A, Baecklund E, Herborn G, Rau R, et al. QUEST-RA: quantitative clinical assessment of patients with rheumatoid arthritis seen in standard rheumatology care in 15 countries. Ann Rheum Dis. 2007;66(11):1491–6.

2. Kirwan JR, Bijlsma JW, Boers M, Shea BJ. Effects of glucocorticoids on radiological progression in rheumatoid arthritis. Cochrane Database Syst Rev. 2007;1, CD006356.

3. Da Silva JAP, Jacobs JWG, Kirwan JR, Boers M, Saag KG, Ines LBS, de Koning EJP, Buttgereit F, Cutolo M, Capell H, et al. Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data. Ann Rheum Dis. 2006;65(3):285–93.

4. Curtis JR, Westfall AO, Allison J, Bijlsma JW, Freeman A, George V, Kovac SH, Spettell CM, Saag KG. Population-based assessment of adverse events associated with long-term glucocorticoid use. Arthritis Rheum. 2006;55(3):420–6.

5. Luqmani R, Hennell S, Estrach C, Basher D, Birrell F, Bosworth A, Burke F, Callaghan C, Candal-Couto J, Fokke C, et al. British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of rheumatoid arthritis (after the first 2 years). Rheumatology (Oxford). 2009;48(4):436–9.

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Initiation of glucocorticoids before entering rheumatology care associates with long-term glucocorticoid use in older adults with early rheumatoid arthritis: A joint analysis of Medicare and the Rheumatology Informatics System for Effectiveness (RISE) data;Seminars in Arthritis and Rheumatism;2024-10

2. Osteoporosis and fracture risk are multifactorial in patients with inflammatory rheumatic diseases;Nature Reviews Rheumatology;2024-06-03

3. The impact of glucocorticoid use on the outcomes of rheumatoid arthritis in a multicenter ultrasound cohort study;International Journal of Rheumatic Diseases;2024-03

4. Continuing versus tapering low-dose glucocorticoids in patients with rheumatoid arthritis and systemic lupus erythematosus in states of low disease activity or remission: A systematic review and meta-analysis of randomised trials;Seminars in Arthritis and Rheumatism;2024-02

5. A path to Glucocorticoid Stewardship: a critical review of clinical recommendations for the treatment of systemic lupus erythematosus;Rheumatology;2024-01-27